Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating fecal microbiota transplantation for autism spectrum disorder, including associated gastrointestinal symptoms. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Autism Spectrum Disorder, Gastrointestinal Diseases | Phase 1, Phase 2 | Status: RECRUITING